SCHEMBL7675074

SCHEMBL7675074

O=C(O)CNS(=O)(=O)c1ccc(NC(=O)c2ccc(-c3ccccc3)cc2)cc1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 2/20 0.74
GAA P10253 1/20 0.74
MMP12 P39900 1/20 0.74
MEN1 O00255 2/20 0.65
PSMD14 O00487 2/20 0.65
POLB P06746 2/20 0.65
MAPT P10636 2/20 0.65
CACNA1B Q00975 2/20 0.65
APBA1 Q02410 2/20 0.65
KMT2A Q03164 2/20 0.65
RECQL P46063 1/20 0.65
CTDSP1 Q9GZU7 1/20 0.65
SAE1 Q9UBE0 1/20 0.65
UBA2 Q9UBT2 1/20 0.65
FGB P02675 1/20 0.64
CYP2C9 P11712 1/20 0.64
CYP2C19 P33261 1/20 0.64
PLEC Q15149 1/20 0.64
NPSR1 Q6W5P4 1/20 0.64
LMNA P02545 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14534186 0.96 MMP1 (0.71) MMP1GAAMMP12MEN1PSMD14
SCHEMBL4834530 0.92 LMNA (0.74) MMP1GAAMMP12MEN1KMT2A
SCHEMBL7673748 0.92 ALDH1A1 (0.74) MMP1GAAMMP12MEN1KMT2A
SCHEMBL7665894 0.88 LMNA (0.60) MMP1GAAMMP12MEN1KMT2A
SCHEMBL7671620 0.86 LMNA (0.59) MMP1GAAMMP12MEN1KMT2A
SCHEMBL10890150 0.86 MMP1 (1.00) MMP1GAAMMP12KMT2AMMP2
SCHEMBL7675070 0.85 PRMT1 (0.68) MEN1POLBMAPTKMT2ALMNA
SCHEMBL7670605 0.85 CA1 (0.63) MEN1POLBKMT2ALMNAALDH1A1
SCHEMBL5099330 0.85 MEN1 (0.62) GAAMEN1POLBMAPTKMT2A
SCHEMBL4832336 0.85 MEN1 (0.62) MEN1KMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US claimed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP claimed
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed